VERTEX PHARMACEUTICALS INC / MA: operating_income
| Value | {"amount": -696077000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2010-01-01 – 2010-12-31 |
| Status | current |
| Entity | VERTEX PHARMACEUTICALS INC / MA |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:42:16.115598+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ad8ab722-b5fd-4e01-b553-146a2b434f66
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-11-001025Retrieved: 2026-08-19T08:42:16.115598+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875320/operating-income/2010-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ad8ab722-b5fd-4e01-b553-146a2b434f66
History
- no predecessors — first report